The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient advocates were in favor of a change in nomenclature and/or definition. A modified Delphi process was led by three large pan-national…
Annals of Hepatology Template
Write in a clean editor, then format for Annals of Hepatology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Annals of Hepatology format
Annals of Hepatology is a peer-reviewed journal published by Elsevier, covering Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Hepatitis C virus research.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Annals of Hepatology 12 (2023) 45–58.
Formats any DOI in Annals of Hepatology style. No sign-up. |
| Publishes research in | Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Hepatitis C virus research Hepatitis B Virus Studies Organ Transplantation Techniques and Outcomes |
| ISSN | 1665-2681 |
| Citation impact (2-yr) | 1.39 |
| h-index | 84 |
| i10-index | 1,256 |
| Total citations | 50,634 |
| Article processing charge | $1,500 |
| Open access | Yes |
| Top institutions publishing here | Hospital Médica Sur |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Annals of Hepatology per year
Citation impact of Annals of Hepatology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Annals of Hepatology
The primary bile acids (BAs) are synthetized from colesterol in the liver, conjugated to glycine or taurine to increase their solubility, secreted into bile, concentrated in the gallbladder during fasting, and expelled in the intestine in response to dietary fat, as well as bio-transformed in the colon to the secondary BAs by the gut microbiota,…
Bile acids (BAs), the end products of cholesterol catabolism, are essential for the absorption of lipids and fat-soluble vitamins; but they have also emerged as novel signaling molecules that act as metabolic regulators. It has been well described that the enterohepatic circulation, a nuclear (FXR) and a cytoplasmic (TGR5/M-BAR) receptor aid in controlling hepatic bile…
BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and liver transplantation in western countries. Increasing incidence of NAFLD has been well documented from Asian countries like Japan and China. Diabetes mellitus (DM), obesity, hyperinsulinemia are predisposing factors for NAFLD. There is increase in incidence of DM, obesity…
BACKGROUND: Probiotics have profound effect on nonalcoholic steatohepatitis (NASH) in animal models. We aimed to test the hypothesis that probiotics treatment was superior to usual care in reducing liver fat in NASH patients. MATERIAL AND METHODS: Patients with histology-proven NASH were randomized to receive probiotics (n = 10) or usual care (n = 10) for…